The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.50
Bid: 4.34
Ask: 4.80
Change: 1.03 (29.68%)
Spread: 0.46 (10.599%)
Open: 3.64
High: 4.50
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wilbur Ellis Agreement

14 Jun 2023 07:00

RNS Number : 6732C
Plant Health Care PLC
14 June 2023
 

14 June 2023

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Plant Health Care® ("PHC") and Wilbur-Ellis® Agribusiness Announce Distribution Agreement to Support First OBRONATM Commercial Sales in the U.S.

 

Plant Health Care® (AIM.PHC.L), a leading provider of peptides for plant protection to global agriculture markets, is pleased to announce it has concluded a distribution agreement ("The Agreement") with Wilbur-Ellis® Agribusiness, one of the largest U.S. retailers of agricultural products. The Agreement will support commercial sales of OBRONATM, a foliar fungicide recently approved by US EPA which is expected to be available within key US markets during the summer of 2023. Obrona is a unique product developed to help growers control a wide range of fungal and bacterial plant pathogens within fruits, nuts, vegetables, and row crops.

 

Plant Health Care and Wilbur-Ellis have been working together in an exclusive partnership since 2020 to evaluate and develop PHC279, the active ingredient in OBRONA, for high value specialty and row crop markets. Multiple years of field trials have validated product efficacy to support initial launch focused on corn diseases, such as tar spot (Phyllachora maydis), Gray leaf spot (Cercospora zeae-maydis), and common rust (Puccinia sorghi), as well as powdery and downy mildew and various other diseases in grapes, as well as white mold (Sclerotinia sclerotiorum) and other diseases affecting leafy vegetables within key Western US states.

 

Derived from naturally occurring proteins, PHC279 is the first product from the Company's PREtec technology platform (Vaccines for Plants™) that will be available to US farmers. PREtec stimulates crop growth and enhances crop resistance to fungal and bacterial diseases and improves crop quality and yield. The Company's initial PREtec product, Saori® is successfully being used in Brazil as a seed treatment to control an array of soybean diseases including Asian Soybean Rust (Phakopsora spp.).

 

PREtec provides growers with a novel and environmentally friendly approach to growing crops and is compatible with mainstream agricultural practices. As part of an integrated pest management program, OBRONA will reduce reliance on older synthetic pesticides and will provide growers with a valuable tool to proactively manage disease resistance. The availability of OBRONA will support farmers seeking to use more sustainable and environmentally friendly practices while continuing to provide safe, abundant, and high-quality food.

 

Plant Health Care continues to expand into new markets around the world through strategic partnerships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025, through the launch of new products and continued growth through current and future distributor relationships, and to achieve cash breakeven and profit along that track.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Having worked with Wilbur-Ellis on the development of OBRONA for more than three years, I am gratified that this new agreement will bring OBRONA to the market to enable control of many of the most recalcitrant fungal and bacterial pathogens challenging growers today. OBRONA will support sustainable agriculture with better crops delivering higher yield for thousands of U.S. farmers."

 

 

Scott Addy, Wilbur-Ellis Agribusiness VP Branded Technologies and Biological Solutions, said: "We are pleased that our partnership with Plant Health Care has resulted in the approval of OBRONA and are looking forward to launching the product this summer to deliver value to the grower in a sustainable way. We expect that there will be many other products that follow, and we will continue to offer our growers biological options to solve their pest issues."

 

 

# # #

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes, and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

Tel: +1 919 926 1600

Cenkos Securities plc - Nomad & Broker Neil McDonald / Pete Lynch

Tel: +44 (0) 131 220 9771

SEC Newgate (Financial Communications) Robin Tozer / George Esmond / Harry Handyside

Tel: +44 (0)7540 106 366 Email: phc@secnewgate.co.uk

For further information about Wilbur-Ellis, please contact:

Jeanne Forbis, email:jforbis@wilburellis.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEASKLFDLDEEA
Date   Source Headline
27th Apr 201211:49 amRNSResearch Agreement with Arysta LifeScience
25th Apr 20122:45 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20123:00 pmRNSTR-1 Notification of Major Interest in Shares
20th Apr 20127:00 amRNSResult of AGM
18th Apr 20127:00 amRNSTR-1 Notification of Major Interest in Shares
17th Apr 20128:23 amRNSDirector/PDMR Shareholding
13th Apr 20122:00 pmRNSDirectorate Change
5th Apr 20127:00 amRNSAgreement with MANA Crop Protection
23rd Mar 201210:30 amRNSHolding(s) in Company
21st Mar 20123:00 pmRNSHolding(s) in Company
19th Mar 20129:45 amRNSPublication of Annual Report
27th Feb 20129:30 amRNSChange of Adviser
27th Feb 20127:00 amRNSFinal Results
20th Feb 20121:30 pmRNSBlocklisting Interim Review
1st Feb 20127:00 amRNSDistribution deal with Agrium subsidiary
18th Jan 20127:00 amRNSTrading Update
11th Jan 201212:10 pmRNSHolding(s) in Company
3rd Jan 20124:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20124:35 pmRNSPrice Monitoring Extension
12th Dec 20117:00 amRNSProduct Update: Harpin
1st Dec 201112:45 pmRNSTotal Voting Rights
23rd Nov 20114:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20114:35 pmRNSPrice Monitoring Extension
10th Nov 20116:00 pmRNSHolding(s) in Company
10th Nov 20114:30 pmRNSHolding(s) in Company
14th Sep 20117:30 amRNSHolding(s) in Company
13th Sep 201111:00 amRNSHolding(s) in Company
8th Sep 20114:00 pmRNSHolding(s) in Company
1st Sep 201110:30 amRNSTotal Voting Rights
1st Sep 20118:00 amRNSStatement re Jeremy Scudamore
22nd Aug 201110:00 amRNSPosting of Interim Report
19th Aug 201110:30 amRNSBLOCK LISTING SIX-MONTHLY RETURN
17th Aug 201110:40 amRNSAdditional Listing and Directors' Shareholdings
15th Aug 20117:00 amRNSHalf Yearly Report
28th Jul 20114:30 pmRNSHolding(s) in Company
1st Jun 20115:00 pmRNSHolding(s) in Company
27th May 20113:00 pmRNSHolding(s) in Company
26th May 20117:00 amRNSTrading Update
14th Apr 20112:51 pmRNSResult of AGM
7th Apr 201110:00 amRNSHolding(s) in Company
21st Mar 201112:00 pmRNSAnnual Financial Report and Notice of AGM
1st Mar 201110:15 amRNSTotal Voting Rights
24th Feb 201110:30 amRNSReplacement Director/PDMR Shareholding
23rd Feb 20111:30 pmRNSDirector/PDMR Shareholding
22nd Feb 201112:15 pmRNSDirector/PDMR Shareholding
21st Feb 20117:01 amRNSFinal Results
18th Feb 20113:00 pmRNSBlocklisting Interim Review
14th Jan 20117:00 amRNSDisposal and Trading Update
12th Jan 20115:30 pmRNSHolding(s) in Company
15th Dec 20102:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.